Gene Delivery in Retinal Diseases
视网膜疾病中的基因传递
基本信息
- 批准号:8519457
- 负责人:
- 金额:$ 35.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdhesivenessAlgorithmsAnteriorApplications GrantsAvidityBackBindingBiodistributionBiological PreservationBlindnessBlood CirculationCaliberCell Culture TechniquesCell NucleusCell membraneCell surfaceCellsClathrinCollaborationsCultured CellsCytoplasmDNADNA SequenceDataDiseaseDoseDrug Delivery SystemsDrug FormulationsDrug KineticsElectroporationElectroretinographyEnhancersEvaluationExtracellular MatrixEyeEyedropsFigs - dietaryGatekeepingGene DeliveryGene ExpressionGene Expression ProfilingGene Therapy AgentGenesGoalsGrantHyaluronanHyaluronic AcidImmune responseKnowledgeLeadLearningLifeMeasuresMediatingMembrane MicrodomainsMicroscopyMicrotubulesMonitorMorphologyMovementMusNuclearParticle SizePatientsPenetrationPharmacologic SubstancePolysaccharidesPublic HealthReporter GenesResearchRetinaRetinalRetinal DiseasesRouteScienceScleraStructure of retinal pigment epitheliumSurfaceSystemTestingTherapeuticTimeTopical applicationTreatment ProtocolsViralVisionbasedesignextracellulargene therapyimprovedin vivoin vivo Modelinherited retinal degenerationinhibitor/antagonistinsightinterstitialmeetingsmouse modelnanoparticlenon-viral gene therapynovelparticleplasmid DNApreventpromoterresearch studysmall moleculesuccesstherapeutic genetraffickinguptake
项目摘要
DESCRIPTION (provided by applicant): Delivery of therapeutic constructs to the posterior eye is an ongoing problem in treating blinding diseases of the retina and retinal pigmented epithelium (RPE). To meet this challenge, our long- term goal is to gain insights into extra- and intracellular trafficking in gene delivery to the RPE. In the past grant period, we demonstrated high in vivo expression of reporter genes in mouse RPE following ocular electroporation with plasmid DNA. Recently, we developed new nanoparticles that have many functional advantages over predecessors due to their specific sizing, core, and shell design. In our preliminary data, we characterized the pharmacokinetics of our new particles. We showed that they reach the posterior segment and transfect retinal cells efficiently, making them ideal for practical gene therapy. Central hypotheses-Hyaluronan coated nanoparticles (HA-NPs) can deliver cargos that other nonviral approaches cannot: 1. They penetrate through interstitial spaces through avidity and adhesiveness. 2. They penetrate cell membranes efficiently through lipid-raft uptake. 3. With aid of inhibitors, they avoid intracellular and cytosolic foreign-DNA host innate defenses. 4.
They can be efficiently transported to the nucleus on microtubules. Our studies will show how the HA-NPs overcome these classic barriers to nonviral gene therapy: We will learn the mechanisms of these four key features. These HA-NPs (and knowledge of their mechanism of delivery, and how to manipulate them for optimized delivery) are likely to be effective in gene therapy where other nonviral gene therapy approaches might not. Impact on Field: This research should improve gene delivery to the point that a patient can self- treat with eye drops. The use of topical eye drops to deliver gene therapy agents to the posterior segment and the RPE is transformative.
描述(由申请人提供):将治疗性构建体递送至后眼是治疗视网膜和视网膜色素上皮(RPE)致盲性疾病的一个持续存在的问题。为了迎接这一挑战,我们的长期目标是深入了解基因递送到RPE的细胞外和细胞内运输。在过去的资助期间,我们证明了在小鼠RPE中报告基因的高体内表达与质粒DNA眼电穿孔。最近,我们开发了新的纳米颗粒,由于其特定的尺寸,核和壳设计,与前辈相比具有许多功能优势。在我们的初步数据中,我们描述了我们的新颗粒的药代动力学。我们发现,它们可以有效地到达后段并切除视网膜细胞,使其成为实用基因治疗的理想选择。中心假设--它们通过嗜酸性和嗜酸性穿透细胞间隙。2.它们通过脂筏摄取有效地穿透细胞膜。3.在抑制剂的帮助下,它们避免细胞内和胞质外源DNA宿主的先天防御。4.
它们可以在微管上被有效地运输到细胞核。我们的研究将展示HA-NPs如何克服非病毒基因治疗的这些经典障碍:我们将了解这四个关键特征的机制。这些HA-NP(及其传递机制的知识,以及如何操纵它们以优化传递)可能在基因治疗中有效,而其他非病毒基因治疗方法可能无效。对领域的影响:这项研究应该改善基因传递到病人可以用眼药水自我治疗的程度。使用局部滴眼液将基因治疗剂递送至眼后段和RPE是变革性的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John M Nickerson其他文献
Development of an Improved Tracheal Explant Bioassay for the Detection of the Ciliary Dyskinesia Factor in Cystic Fibrosis Serum
一种用于检测囊性纤维化血清中纤毛运动障碍因子的改良气管外植体生物测定法的开发
- DOI:
10.1203/00006450-197901000-00007 - 发表时间:
1979-01-01 - 期刊:
- 影响因子:3.100
- 作者:
Michael G Gabridge;Marlene J Bright;C Coe Agee;John M Nickerson;Nanine S Henderson - 通讯作者:
Nanine S Henderson
John M Nickerson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John M Nickerson', 18)}}的其他基金
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)
眼睛生长、正视眼和感光器间视黄醇结合蛋白 (IRBP)
- 批准号:
8439134 - 财政年份:2013
- 资助金额:
$ 35.84万 - 项目类别:
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)
眼睛生长、正视眼和感光器间视黄醇结合蛋白 (IRBP)
- 批准号:
8662781 - 财政年份:2013
- 资助金额:
$ 35.84万 - 项目类别:
Topical delivery of nanoencapsulated plasmid DNA to posterior ocular targets
将纳米封装的质粒 DNA 局部递送至眼后部目标
- 批准号:
8252690 - 财政年份:2012
- 资助金额:
$ 35.84万 - 项目类别:
相似海外基金
DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
- 批准号:
EP/Y029089/1 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
- 批准号:
2337776 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
- 批准号:
2338846 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
- 批准号:
2348261 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
- 批准号:
2348346 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
- 批准号:
2348457 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
- 批准号:
2404989 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
- 批准号:
2339310 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
- 批准号:
2339669 - 财政年份:2024
- 资助金额:
$ 35.84万 - 项目类别:
Continuing Grant